Paper21652011
Notch-ing from T-cell to B-cell lymphoid malignancies.
Mirandola L and 5 others. Cancer Lett, 2011. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Notch-ing from T-cell to B-cell lymphoid malignancies. Papers, record 21652011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21652011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Hematologic Neoplasms | Major topic |
| Receptors, Notch | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Humans | |
| Leukemia, Lymphocytic, Chronic, B-Cell | |
| Lymphoma, B-Cell | |
| Multiple Myeloma | |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | |
| Stem Cells |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39544933 | Therapeutic potential of natural coumarins in autoimmune diseases with underlying mechanisms. | Front Immunol | 2024 | https://conductscience.org/library/papers/39544933 | PubMed |
| 39071599 | Agrimonolide mitigated DSS-induced colitis by modulating the balance between Treg and Th17 cells through the suppression of the Notch and JAK2/STAT3 signaling pathways. | Heliyon | 2024 | https://conductscience.org/library/papers/39071599 | PubMed |
| 35611214 | Transcriptomics-Based Investigation of Molecular Mechanisms Underlying Apoptosis Induced by ZnO Nanoparticles in Human Diffuse Large B-Cell Lymphoma. | Int J Nanomedicine | 2022 | https://conductscience.org/library/papers/35611214 | PubMed |
| 33918655 | Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33918655 | PubMed |
| 32963611 | Mutational analysis of extranodal marginal zone lymphoma using next generation sequencing. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32963611 | PubMed |
| 31582544 | Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance. | Haematologica | 2020 | https://conductscience.org/library/papers/31582544 | PubMed |
| 29903986 | Effect of Notch and PARP Pathways' Inhibition in Leukemic Cells. | Cells | 2018 | https://conductscience.org/library/papers/29903986 | PubMed |
| 29104587 | Notch and its oncogenic activity in human malignancies. | Eur Surg | 2017 | https://conductscience.org/library/papers/29104587 | PubMed |
| 27572051 | Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma. | Mol Med Rep | 2016 | https://conductscience.org/library/papers/27572051 | PubMed |
| 27463014 | Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche. | Oncotarget | 2016 | https://conductscience.org/library/papers/27463014 | PubMed |
| 26848618 | Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3. | Oncotarget | 2016 | https://conductscience.org/library/papers/26848618 | PubMed |
| 26308486 | Notch signaling deregulation in multiple myeloma: A rational molecular target. | Oncotarget | 2015 | https://conductscience.org/library/papers/26308486 | PubMed |
| 25257302 | Notch signaling drives multiple myeloma induced osteoclastogenesis. | Oncotarget | 2014 | https://conductscience.org/library/papers/25257302 | PubMed |
| 24968698 | Genomic characterization of acute leukemias. | Med Princ Pract | 2014 | https://conductscience.org/library/papers/24968698 | PubMed |
| 24959528 | The challenge of targeting notch in hematologic malignancies. | Front Pediatr | 2014 | https://conductscience.org/library/papers/24959528 | PubMed |
| 24829804 | Molecularly targeted therapies in multiple myeloma. | Leuk Res Treatment | 2014 | https://conductscience.org/library/papers/24829804 | PubMed |
| 23536563 | Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma. | Cancer Res | 2013 | https://conductscience.org/library/papers/23536563 | PubMed |
| 23354012 | Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1. | Leukemia | 2013 | https://conductscience.org/library/papers/23354012 | PubMed |
| 23307030 | Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes. | Leukemia | 2013 | https://conductscience.org/library/papers/23307030 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21652011
GET https://conductscience.org/api/papers/v1/21652011/authors